top of page
PREHEALING

Healing Perspectives & Protocols
Low-Dose Allergens (LDA) and Enzyme-Potentiated Desensitization (EPD) Part 1
Historical Foundations and Modern Applications of Ultra-Low-Dose Immunotherapy Low-dose allergen therapy, known as LDA, and its predecessor enzyme-potentiated desensitization, known as EPD, represent a distinctive lineage within the broader field of immunotherapy. These approaches use extremely dilute preparations of allergens and other biological substances, combined with an enzyme catalyst, to modulate immune responses and reduce hypersensitivity. Developed over half a cent
Low-Dose Allergens (LDA) and Enzyme-Potentiated Desensitization (EPD) Part 2
The Deeper Science, the Living Context, and the Road to Legitimacy The first part of this essay traced the history of enzyme-potentiated desensitization and its modern descendant, low-dose allergen therapy. We explored the origins of the approach in Leonard McEwen's work, the basic immunological principles that might explain its effects, the practical methodology, and the current state of the evidence. We also acknowledged the significant challenges that have kept these thera
Low-Dose Allergens (LDA) and Enzyme-Potentiated Desensitization (EPD) Part 3
The Antigen Mixtures in Practice and a Laboratory Guide for Experimental Investigation The first two parts of this essay explored the history, mechanisms, clinical applications, and controversies surrounding EPD and LDA. We traced the lineage from Leonard McEwen's early work to modern practice, and we examined the deeper science of the enzyme, the skin, the dosing interval, and the placebo question. But for a student, clinician, or researcher who wishes to go further, a more
bottom of page